Canada Pension Plan Investment Board
NKTR icon

Canada Pension Plan Investment Board’s Nektar Therapeutics NKTR Stock Holding History

Canada Pension Plan Investment Board’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-400
Closed -$16.9K – 1911
2025
Q4 		$16.9K Buy
+400
New +$22.4K ﹤0.01% 1948
2021
Q4 		– Sell
-3
Closed -$1K – 1561
2021
Q3 		$1K Hold
3
– – ﹤0.01% 1356
2021
Q2 		$1K Sell
3
-214
-99% -$59.2K ﹤0.01% 1133
2021
Q1 		$65K Sell
217
-1,092
-83% -$340K ﹤0.01% 1203
2020
Q4 		$334K Sell
1,309
-16
-1% -$4.13K ﹤0.01% 1185
2020
Q3 		$330K Sell
1,325
-789
-37% -$248K ﹤0.01% 880
2020
Q2 		$734K Buy
2,114
+1,949
+1,181% +$608K ﹤0.01% 997
2020
Q1 		$44K Buy
+165
New +$51K ﹤0.01% 1208

Other funds holding NKTR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Canada Pension Plan Investment Board's NKTR Position: Q1 2026 in Review

Canada Pension Plan Investment Board sold out of Nektar Therapeutics (NKTR) in Q1 2026, closing a stake of 400 shares — an estimated $16.9K sold.

Canada Pension Plan Investment Board first reported a position in NKTR in Q1 2020 and held it in 8 quarters. The position peaked at $734K in Q2 2020. 215 funds tracked by Wall St. Rank hold NKTR as of Q1 2026.

  • Canada Pension Plan Investment Board reported no remaining Nektar Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Canada Pension Plan Investment Board sold 400 Nektar Therapeutics shares in Q1 2026, an estimated $16.9K.
  • Canada Pension Plan Investment Board first reported a position in Nektar Therapeutics in Q1 2020 and held it in 8 quarters.
  • Canada Pension Plan Investment Board's Nektar Therapeutics position peaked at $734K in Q2 2020.
  • 215 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q1 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q1 2026, filed 15 May 2026.